1: Non-invasive [2,17] |
NI |
waist circumference, alcohol consumption, smoking, systolic blood pressure, family history of T2D |
2: Non-invasive+metabolomics |
NIMet |
AM + sorbitol, galacticol, mannose, galactose, uric acid, oxalic acid, glucaric acid-1,4-lactone, 3-methyl-2-oxopentanoic acid, 2-hydroxybutyric acid |
3: Adiponectin [2] |
AdM |
serum adiponectin, HOMA IR, smoking, IGT, IFG |
4: Adiponectin + metabolomics |
AdMMet |
AdM + sorbitol, galacticol, mannose, galactose, uric acid, oxalic acid, glucaric acid-1,4-lactone, 3-methyl-2-oxopentanoic acid, 2-hydroxybutyric acid |
5: Metabolomics model |
Met |
sorbitol, galacticol, mannose, galactose, uric acid, oxalic acid, glucaric acid-1,4-lactone, 3-methyl-2-oxopentanoic acid, 2-hydroxybutyric acid |
6: Optimized metabolomics |
OMet |
galacticol, mannose, galactose and 2-hydroxybutyric acid |
7: Adiponectin without glucose measures |
AdM2 |
serum adiponectin, HOMA IR, smoking |
8: Optimized metabolomics with glucose measures |
OMet2 |
IFG, IGT, galacticol, mannose, galactose and 2-hydroxybutyric acid |